Curated News
By: NewsRamp Editorial Staff
June 18, 2026
Earth Science Tech Reports 11% Net Income Growth in Fiscal 2026 Results
TLDR
- Earth Science Tech's 11% net income increase and aggressive share repurchases signal strong value creation for investors.
- Earth Science Tech's integrated healthcare platform combines telemedicine, pharmacy, and fulfillment to drive revenue growth.
- Earth Science Tech's expanding healthcare platform improves patient access to integrated care from consultation to fulfillment.
- Earth Science Tech repurchased over 7.1 million shares, boosting shareholder value while avoiding new debt.
Impact - Why it Matters
This news matters because it demonstrates Earth Science Tech's ability to grow revenue, profit, and assets while simultaneously reducing share count through buybacks—a combination that can enhance shareholder value. For investors and stakeholders in the health-tech space, the company's integrated platform model and debt-free growth strategy offer a compelling case study in sustainable expansion within the competitive healthcare sector.
Summary
Earth Science Tech (OTC: ETST) reported strong financial results for its fiscal year ended March 31, 2026, showcasing robust growth across key metrics. Revenue reached $35.7 million, an 8% increase from the prior year, while gross profit climbed 5% to $25.5 million. Net income rose 11% to $3.6 million, reflecting the company's operational efficiency and strategic focus. Total assets surged 27% year over year to $9.0 million, underscoring the expansion of its integrated healthcare platform, which spans telemedicine, pharmacy, and fulfillment services. The company also highlighted its capital allocation strategy, having repurchased and retired over 4 million shares during fiscal 2026 and more than 7.1 million shares cumulatively through subsequent periods. Management emphasized that the company generated positive operating cash flow and strengthened its balance sheet without incurring additional debt, positioning it well for future growth initiatives, product expansion, and continued share repurchases as it enters fiscal 2027.
Earth Science Tech operates as a diversified holding company in the health and wellness sector, building a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. This seamless integration from consultation to fulfillment is achieved through its specialized subsidiaries, creating a unique value proposition in the healthcare market. The company's focus on operational synergy and patient-centric care has driven its financial success and asset growth.
The news release was disseminated by BioMedWire (“BMW”), a specialized communications platform covering the Biotechnology, Biomedical Sciences, and Life Sciences sectors. BMW is part of the Dynamic Brand Portfolio @ IBN, which offers a range of services including press release distribution via InvestorWire, editorial syndication to 5,000+ outlets, and enhanced press release solutions. For the full press release, visit https://ibn.fm/NpjTw, and for the latest updates on ETST, see the company’s newsroom at https://ibn.fm/ETST.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, Earth Science Tech Reports 11% Net Income Growth in Fiscal 2026 Results
